EMEA (Europe, Middle East and Africa) Paroxysmal Nocturnal Hemoglobinuria Treatment Market Report 2018

February 2018 | 114 pages | ID: E152D29CA38EN
QYResearch

Abstracts

In this report, the EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Paroxysmal Nocturnal Hemoglobinuria Treatment for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment market competition by top manufacturers/players, with Paroxysmal Nocturnal Hemoglobinuria Treatment sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Achillion Pharmaceuticals Inc
• Akari Therapeutics Plc
• Alexion Pharmaceuticals Inc
• Alnylam Pharmaceuticals Inc
• Amgen Inc
• Apellis Pharmaceuticals Inc
• F. Hoffmann-La Roche Ltd
• ISU ABXIS Co Ltd
• Novartis AG
• NovelMed Therapeutics Inc
• Omeros Corp
• Ra Pharmaceuticals Inc
• Regeneron Pharmaceuticals Inc
• Regenesance BV

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• ACH-4471
• ALN-CC5
• ALXN-1210
• AMY-101
• APL-2
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Paroxysmal Nocturnal Hemoglobinuria Treatment Market Report 2018

1 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATMENT OVERVIEW

1.1 Product Overview and Scope of Paroxysmal Nocturnal Hemoglobinuria Treatment
1.2 Classification of Paroxysmal Nocturnal Hemoglobinuria Treatment
  1.2.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 ACH-4471
  1.2.4 ALN-CC5
  1.2.5 ALXN-1210
  1.2.6 AMY-101
  1.2.7 APL-2
  1.2.8 Others
1.3 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Application/End Users
  1.3.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Region
  1.4.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Paroxysmal Nocturnal Hemoglobinuria Treatment (2013-2025)
  1.5.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Growth Rate (2013-2025)

2 EMEA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sale Price by Players (2013-2018)
2.2 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sale Price by Type (2013-2018)
2.3 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment (Volume) by Application
2.4 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment (Volume and Value) by Region
  2.4.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Price by Region (2013-2018)

3 EUROPE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Value (2013-2018)
  3.1.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Growth Rate (2013-2018)
3.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Type
3.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Application
3.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume by Countries (2013-2018)
  3.4.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Countries (2013-2018)
  3.4.3 Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  3.4.4 France Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  3.4.5 UK Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  3.4.6 Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  3.4.7 Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)

4 MIDDLE EAST PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Value (2013-2018)
  4.1.1 Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Growth Rate (2013-2018)
4.2 Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Type
4.3 Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Application
4.4 Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  4.4.4 Israel Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  4.4.5 UAE Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  4.4.6 Iran Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)

5 AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Value (2013-2018)
  5.1.1 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Growth Rate (2013-2018)
5.2 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Type
5.3 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Application
5.4 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume by Countries (2013-2018)
  5.4.2 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Countries (2013-2018)
  5.4.3 South Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2018)

6 EMEA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Achillion Pharmaceuticals Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Akari Therapeutics Plc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Alexion Pharmaceuticals Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Alnylam Pharmaceuticals Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Amgen Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Apellis Pharmaceuticals Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 F. Hoffmann-La Roche Ltd
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 ISU ABXIS Co Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Novartis AG
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 NovelMed Therapeutics Inc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Omeros Corp
6.12 Ra Pharmaceuticals Inc
6.13 Regeneron Pharmaceuticals Inc
6.14 Regenesance BV

7 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATMENT MANUFACTURING COST ANALYSIS

7.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Paroxysmal Nocturnal Hemoglobinuria Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATMENT MARKET FORECAST (2018-2025)

11.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Price and Trend Forecast (2018-2025)
11.2 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Forecast by Type (2018-2025)
11.7 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Paroxysmal Nocturnal Hemoglobinuria Treatment
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure ACH-4471 Product Picture
Figure ALN-CC5 Product Picture
Figure ALXN-1210 Product Picture
Figure AMY-101 Product Picture
Figure APL-2 Product Picture
Figure Others Product Picture
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Million USD) by Region (2013-2025)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume and Growth Rate (2013-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Players (2013-2018)
Figure 2017 Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Players
Figure 2017 Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Players
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) by Players (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Players (2013-2018)
Table 2017 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Players
Table 2017 EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Players
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Type (2013-2018)
Figure Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Type (2013-2018)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Type (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Type in 2017
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Application (2013-2018)
Figure Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Application (2013-2018)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Application in 2017
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Region (2013-2018)
Figure Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Region (2013-2018)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in 2017
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Region (2013-2018)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share Regions in 2017
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Growth Rate (2013-2018)
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Type (2013-2018)
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2013-2018)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type in 2017
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Application (2013-2018)
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2013-2018)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application in 2017
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Countries (2013-2018)
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Countries (2013-2018)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Countries (2013-2018)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Countries in 2017
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) by Countries (2013-2018)
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries in 2017
Figure Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Type (2013-2018)
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2013-2018)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Type (2013-2018)
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Applications (2013-2018)
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Applications (2013-2018)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Application in 2017
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Market Share by Countries in 2017
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Type (2013-2018)
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Type (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Type (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Type in 2017
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Application (2013-2018)
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Application (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Application (2013-2018)
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Countries (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Countries (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Countries in 2017
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) by Countries (2013-2018)
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries (2013-2018)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Countries in 2017
Figure South Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in EMEA (2013-2018)
Figure NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in EMEA (2013-2018)
Table Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Paroxysmal Nocturnal Hemoglobinuria Treatment
Figure Manufacturing Process Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment
Figure Paroxysmal Nocturnal Hemoglobinuria Treatment Industrial Chain Analysis
Table Raw Materials Sources of Paroxysmal Nocturnal Hemoglobinuria Treatment Major Manufacturers in 2017
Table Major Buyers of Paroxysmal Nocturnal Hemoglobinuria Treatment
Table Distributors/Traders List
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share Forecast by Region (2018-2025)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share Forecast by Region (2018-2025)
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share Forecast by Type (2018-2025)
Table EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources